Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?
Yıl: 2021 Cilt: 4 Sayı: 3 Sayfa Aralığı: 224 - 229 Metin Dili: İngilizce DOI: 10.30714/j-ebr.2021370081 İndeks Tarihi: 08-10-2021
Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?
Öz: Aim: The triglyceride / HDL cholesterol (TG/HDL-c) ratio is increased in a variety of diseases including, coronary heart disease and type 2 diabetes mellitus. However, its role in non-alcoholic hepatosteatosis is not well understood. In present study, we aimed to compare the TG/HDL-c levels of the patients with non-alcoholic hepatosteatosis to those of the healthy subjects. Methods: Medical data of the patients with non-alcoholic hepatosteatosis whom presented to the outpatient internal medicine clinics of our institution were retrospectively analyzed. Healthy subjects whom admissions to our clinics were due to check up were enrolled to the study as control group. TG/HDL-c of the groups compared. Results: TG/HDL-c level of the liver steatosis group (5 (2-22) %) was higher than the control group (2.7 (1-8) %), (p<0.001). TG/HDL-c was significantly and positively correlated with fasting blood glucose (r=0.31, p<0.001), C - reactive protein (r=0.25, p<0.001) and LDL-cholesterol (r=0.3, p<0.001) levels. A TG/HDL-c value greater than 3.1% has 91% sensitivity and 77% specificity in detecting hepatosteatosis. Conclusions: We suggest that TG/HDL-c ratio could be a useful marker of non-alcoholic hepatosteatosis due to its inexpensive and easy to assess nature.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- [1]Keenan T, Blaha MJ, Nasir K et al. Relation of uric acid to serum levels of highsensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol. 2012; 110 (12): 1787-92.
- [2]Aktas G, Alcelik A, Tekce BK et al. Mean platelet volume and red cell distribution width in hepatosteatosis. Natl J Med Res. 2013; 3 (3): 264-66.
- [3]Aktas G, Duman TT, Kurtkulagi O et al. Liver Steatosis is Associated Both with Platelet Distribution Width, Neutrophil/Lymphocyte and Monocyte/Lymphocyte Ratios. Prim Health Care Open Access. 2020; 10 (4): 1-4.
- [4]Kosekli MA, Erkus E, Kocak MZ. Mean Platelet Volume to Platelet ratio as a promising marker of hepatosteatosis. Exp Biomed Res. 2018; 1 (2): 55-59.
- [5]Rodak AP, Kiciak S, Tomasiewicz K. Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B. Ann Agricul Environ Med. 2018; 25 (4): 690-92.
- [6]Hadaegh F, Khalili D, Ghasemi A et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009; 19 (6): 401-08.
- [7]Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in nondiabetic, healthy subjects without prominent hyperlipidemia. J Atheroscleros Thrombos. 2003; 10 (3): 186-91.
- [8]Murguía-Romero M, Jiménez-Flores JR, Sigrist-Flores SC et al. Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 2013; 54 (10): 2795-99.
- [9]Xia W, Yao X, Chen Y et al. Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients. BMC Nephrol. 2020; 21 (1): 324.
- [10]Liu PJ, Liu Y, Ma L et al. The Predictive Ability of Two Triglyceride-Associated Indices for Gestational Diabetes Mellitus and Large for Gestational Age Infant Among Chinese Pregnancies: A Preliminary Cohort Study. Diab Metab Syndr Obes: targets and therapy 2020; 13: 2025-35.
- [11]Schairer C, Laurent CA, Moy LM et al. Obesity and related conditions and risk of inflammatory breast cancer: a nested casecontrol study. Breast Cancer Res Treat. 2020; 183 (2): 467-78.
- [12]da Luz PL, Favarato D, Faria-Neto JR, Jr. et al. High ratio of triglycerides to HDLcholesterol predicts extensive coronary disease. Clinics (Sao Paulo, Brazil) 2008; 63 (4): 427-32.
- [13]Shishehbor MH, Hoogwerf BJ, Lauer MS. Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery. Diabetes Care 2004; 27 (4): 936-41.
- [14]Gonzalez-Chavez A, Simental-Mendia LE, Elizondo-Argueta S. Elevated triglyceride/HDL-cholesterol ratio associated with insulin resistance. Cirugia y cirujanos. 2011; 79 (2): 126-31.
- [15]Vega GL, Barlow CE, Grundy SM et al. Triglyceride-to-high-density-lipoproteincholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Invest Med. 2014; 62 (2): 345-9.
- [16]Karelis AD, Pasternyk SM, Messier L et al. Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study. Appl Physiol Nutr Metab. 2007; 32 (6): 1089-96.
| APA | Kurtkulagi O, Bilgin S, kahveci g, Atak B, kosekli m (2021). Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. , 224 - 229. 10.30714/j-ebr.2021370081 |
| Chicago | Kurtkulagi Ozge,Bilgin Satılmış,kahveci gizem,Atak Burcin Meryem,kosekli mehmet ali Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. (2021): 224 - 229. 10.30714/j-ebr.2021370081 |
| MLA | Kurtkulagi Ozge,Bilgin Satılmış,kahveci gizem,Atak Burcin Meryem,kosekli mehmet ali Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. , 2021, ss.224 - 229. 10.30714/j-ebr.2021370081 |
| AMA | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. . 2021; 224 - 229. 10.30714/j-ebr.2021370081 |
| Vancouver | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. . 2021; 224 - 229. 10.30714/j-ebr.2021370081 |
| IEEE | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m "Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?." , ss.224 - 229, 2021. 10.30714/j-ebr.2021370081 |
| ISNAD | Kurtkulagi, Ozge vd. "Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?". (2021), 224-229. https://doi.org/10.30714/j-ebr.2021370081 |
| APA | Kurtkulagi O, Bilgin S, kahveci g, Atak B, kosekli m (2021). Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. Experimental Biomedical Research, 4(3), 224 - 229. 10.30714/j-ebr.2021370081 |
| Chicago | Kurtkulagi Ozge,Bilgin Satılmış,kahveci gizem,Atak Burcin Meryem,kosekli mehmet ali Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. Experimental Biomedical Research 4, no.3 (2021): 224 - 229. 10.30714/j-ebr.2021370081 |
| MLA | Kurtkulagi Ozge,Bilgin Satılmış,kahveci gizem,Atak Burcin Meryem,kosekli mehmet ali Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. Experimental Biomedical Research, vol.4, no.3, 2021, ss.224 - 229. 10.30714/j-ebr.2021370081 |
| AMA | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. Experimental Biomedical Research. 2021; 4(3): 224 - 229. 10.30714/j-ebr.2021370081 |
| Vancouver | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?. Experimental Biomedical Research. 2021; 4(3): 224 - 229. 10.30714/j-ebr.2021370081 |
| IEEE | Kurtkulagi O,Bilgin S,kahveci g,Atak B,kosekli m "Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?." Experimental Biomedical Research, 4, ss.224 - 229, 2021. 10.30714/j-ebr.2021370081 |
| ISNAD | Kurtkulagi, Ozge vd. "Could triglyceride to high density lipoprotein-cholesterol ratio predict hepatosteatosis?". Experimental Biomedical Research 4/3 (2021), 224-229. https://doi.org/10.30714/j-ebr.2021370081 |
